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Abstract
Background: The impact of humanitarian disasters upon mental health is well recognised. The evidence for
psychological interventions for mental health is mounting, but few interventions have been rigorously tested
in humanitarian settings. To be sustainable in humanitarian settings interventions need to be short, simple,
deliverable by nonspecialists under supervision, and adopt a transdiagnostic approach where an array of mental health
outcomes are addressed simultaneously. These elements have been incorporated into the newly developed WHO
Problem Management Plus (PM+) Group intervention. The aim of this trial is to evaluate the locally adapted PM+
Group intervention for women in Swat, Pakistan.
Methods: This PM+ Group trial is a two-arm, single-blind, cluster randomised controlled trial conducted in a
community-based setting with women in rural Pakistan. PM+ is delivered in partnership with the Lady Health Worker
(LHW) Programme which provides community-based health care to women in Pakistan. Thirty-four LHW clusters will
be randomised in a 1:1 allocation ratio using a permuted-block randomisation method. Participants screened and
found to meet the inclusion criteria will be allocated to either the PM+ intervention group (n = 306), or the control arm
(n = 306). The manualised PM+ intervention involves five sessions, each lasting 3 h, and introduces four strategies
applied by participants to problems that they are facing. It is delivered by local female facilitators with a minimum of
16 years of education who are provided with targeted training and supervision. The primary outcome is individual
psychological distress, measured by levels of anxiety and depression on the Hospital Anxiety and Depression Scale at
20 weeks after baseline. Secondary outcomes include major depression, post-traumatic stress disorder, levels of social
support, levels of functioning, and economic effectiveness. Intervention acceptability will be explored through an
embedded qualitative study.
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Discussion: The PM+ Group trial will provide important evidence on the effectiveness of an empirically supported
psychological treatment delivered by nonspecialists in a humanitarian setting. If proven effective, the qualitative
component will inform strategies for PM+ Group scale-up in health systems in other humanitarian settings.
Trial registration: Australian New Zealand Clinical Trials Registry, identifier: ACTRN12616000037404. Registered
on 19 January 2016; WHO Protocol ID RPC705, v.4, 2 November 2015.
Keywords: Mental health and psychosocial support, Cluster randomised controlled trial, Effectiveness,
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Background
Globally, common mental disorders account for a
sizeable proportion of the burden of disease [1]. The
mental health impacts of events including conflict and
humanitarian disaster, and associated adverse and
chronic stressors, such as displacement, poverty, un-
employment, bereavement, and interpersonal conflict,
are well recognised [2–4]. There is an established evidence
base for the effectiveness of psychological treatments, such
as cognitive behavioural therapy, for mental health prob-
lems related to trauma, loss, and extreme stressors [5];
however, with some exceptions [6–10], the majority of
studies have been carried out in high-income settings or on
specialist-led interventions [11]. It is important to establish
whether similar interventions are effective when delivered
by nonspecialists in humanitarian settings, offering feasible
means of reaching the large numbers of people affected by
conflict and other disasters.
Humanitarian emergencies frequently lead to destruc-
tion, death, disease/disorders, and disarray that can over-
whelm local capacity [12]; for instance health and social
systems lacking the human resources to reach those in
need [13]. To address these challenges psychological in-
terventions that are brief, simple, effective, deliverable by
nonspecialists under supervision [14–16], and adopt a
transdiagnostic approach to apply the same underlying
principles across an array of common mental health
problems without tailoring the protocol to specific diag-
noses [17], should be developed and tested.
To ensure that services meet a range of needs and
beneficiary groups it is important to develop not only
individual but also group versions of interventions. A
meta-analysis comparing 15 studies of individual and
group psychological treatments found that while indi-
vidual treatments outperformed group formats in the
reduction of post-treatment symptoms, at 6-month
follow-up both formats were equally as effective [18].
While individual treatments may offer greater confiden-
tiality and personalised care, group formats have other
potential advantages, including the therapeutic benefits
of peer interaction and potential for group members to
be therapeutic agents to each other [19]. They should
also be able to reach larger numbers of people, thus may
offer a cost-effective means of intervening.
Findings from the process evaluation of a pilot rando-
mised controlled trial conducted in the conservative region
of Peshawar, Pakistan indicate that a facility-based individ-
ual psychological treatment would not be accessible for
many women [20]. One way to increase accessibility is
to adopt a community-based approach [21], such as via
Pakistan’s established Lady Health Worker (LHW)
programme, where community health workers provide pri-
mary health care to women and children. Furthermore, as a
result of conflict, conservative norms in Swat, the district
that we are studying, appear to have heightened, impacting
upon women’s access to health services [22]. Therefore,
psychological interventions can be expected to be more ac-
cessible if they are embedded within trusted services, facili-
tating contact with women in need. In the case of Swat, the
LHW programme offers a viable option for community-
based group delivery of psychological interventions to
women who may otherwise be unable to access care.
This study builds on and extends existing evidence re-
lating to potentially scalable psychological interventions
delivered in humanitarian settings by testing a newly de-
veloped WHO transdiagnostic intervention, PM+ Group,
delivered by LHWs in Swat District, Pakistan [23]. Add-
itionally, this study aims to contribute essential evidence
in humanitarian settings by examining the effectiveness
of PM+ Group that incorporates key evidence-based
strategies and models of service delivery.
Methods
Objectives and hypothesis
The objectives of this cluster randomised controlled trial
(cRCT) are to evaluate the effectiveness and cost-
effectiveness of the locally adapted PM+ Group interven-
tion for women in Swat, Pakistan as compared to enhanced
usual care (EUC; defined below). The primary objective is
to test the effectiveness of PM+ Group in reducing symp-
toms of psychological distress (anxiety and depression) in
women in Swat. The secondary objectives are to assess im-
provements in levels of functioning, major depression,
symptoms of post-traumatic stress disorder (PTSD),
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perceived social support, and economic outcomes. To com-
plement this quantitative data, a qualitative component will
explore intervention acceptability amongst stakeholders in-
cluding participants, families, and PM+ Group facilitators.
The primary hypothesis is that women receiving PM+
Group will achieve lower psychological distress (depres-
sion and anxiety) scores in comparison to the EUC control
group at 20 weeks. Secondary hypotheses are that:
1. Women receiving the intervention will report
improved levels of functioning and social support,
assessed at post-assessment at 7 weeks, and follow-
up endpoint assessments at 20 weeks
2. Women receiving the intervention will incur lower
days out of role and lower health costs at 20 weeks
Design and setting
This is a two-arm, single-blind, cluster randomised con-
trolled superiority trial conducted in a community-based
setting with women in rural Pakistan. A cRCT was
favoured to reduce the likelihood of contamination be-
tween the two groups. The Standard Protocol Items:
Recommendations for Interventional Trials (SPIRIT) fig-
ure 2013 is provided in Fig. 1, and the SPIRIT Checklist
accompanies this paper as Additional file 1.
This community-based study is being conducted in Odi-
gram and Ghalegay Union Councils in Swat District,
Pakistan. A Union Council is the smallest administrative
unit in Pakistan, each with a population of approximately
25,000. Each Union Council has a Basic Health Unit
(BHU) – a primary health care facility staffed by a primary
care physician, a Lady Health Visitor, a vaccinator, and
15–20 community-based LHWs. LHWs are female com-
munity health workers trained to provide maternal and
child health care. They receive no training in the assess-
ment and management of common mental health prob-
lems and typically have 10 years of education. Employed
by the Government, each LHW is responsible for a catch-
ment area of approximately 1000 people or 150 homes,
visiting five to seven homes daily, covering approximately
85% of the population [24, 25]. Odigram and Ghalegay
Union Councils have 23 and 22 LHWs respectively. These
LHW catchment areas constitute our cluster sampling
frame from which 34 LHW catchment areas across the
two Union Councils are involved in this study. The LHW
role in supporting this study is explained below.
PM+ Group intervention
PM+ is a brief WHO psychological intervention based
on evidence of established behavioural techniques for
Fig. 1 Flow chart of the study procedures
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addressing symptoms of common mental health prob-
lems in low- and middle-income countries. The manua-
lised intervention involves empirically supported strategies
of problem-solving, behavioural activation, accessing social
support, and stress management training [23, 26]. Prior to
implementation, a period of formative work was under-
taken to contextually adapt the intervention and training
materials for delivery to women in Swat, Pakistan, and a
pilot trial conducted [27].
PM+ Group is an adaptation of the individual PM+
intervention. It was developed through 6 months of for-
mative work, including review by 28 international ex-
perts. The group intervention (manual available upon
request) involves five weekly sessions each lasting for
3 h, inclusive of breaks. The first session opens with psy-
choeducation, including information on common reac-
tions to adversity, the rationale for PM+, goal setting,
and brief motivational interviewing. Sessions 1 to 4 each
introduce a strategy: (1) Managing Stress, (2) Managing
Problems, (3) Get Going, Keep Doing (i.e., behavioural
activation), and (4) Strengthening Social Support that
are applied by participants to problems that they are fa-
cing. Each strategy is reviewed in subsequent sessions,
with application of strategies between sessions encour-
aged to enhance learning through repetition. The final
session involves a revision of learning, education on pre-
venting relapse, and ends with a culturally appropriate
closing ceremony. To enhance accessibility for illiterate
individuals the programme is structured around locally
relevant and appropriate pictorial materials and adopts a
narrative format to support engagement and individual
disclosure of personal difficulties which can be more dif-
ficult in a group format. Specifically, a case example of a
woman experiencing common practical and emotional
problems is shared each week, with participants follow-
ing her progress through PM+ Group.
LHWs provide logistical support to PM+ Group facili-
tators, including the provision of a room in her house in
which to conduct sessions, and convening sessions with
participants from her catchment area. LHWs do not de-
liver the intervention, this is done by female facilitators.
The PM+ Group female facilitators are recruited from
Swat and have a minimum of 16 years of education and
no previous experience in providing mental health care.
Facilitators received 7 days of intervention training, de-
livered by the master trainer (KSD) and supported by
three in-country supervisors (PA, HN, AM). Prior to
attending training in PM+, facilitators underwent a half-
day orientation to Psychological First Aid (Urdu version)
[28] to sensitise them on how to appropriately respond
to current crises a woman may be experiencing. Inter-
vention training included education on adversity and its
impact upon mental health, basic counselling skills, de-
livering PM+, skills in group facilitation, and facilitator
self-care. An additional half-day security training for
working in unstable settings was also provided. To build
confidence and competence following training, all facili-
tators delivered one practice group each at an acceler-
ated rate (five sessions in 2 weeks), with participants
living outside the trial area, under intensive supervision.
After conclusion of practice groups all facilitators under-
went competency assessments prior to delivery of PM+
Group to cRCT participants. In case of insufficient com-
petency additional targeted training is provided and
competency assessments readministered. A co-facilitator
who occupies a support role (e.g., providing child care
and supporting LHWs with logistical arrangements) sup-
ports facilitators in each group. Co-facilitators partici-
pated in a half-day orientation to their role delivered by
the facilitators.
Consistent with an apprenticeship model [16], proto-
col adherence is ensured through weekly supervision of
the facilitators provided by three trained PM+ Group su-
pervisors based in Islamabad; and fortnightly supervision
of the supervisors by the master trainer. Involving all fa-
cilitators in a group, supervision lasts 2 to 3 h, con-
ducted via Skype. Supervision entails reviewing the
progress of groups including case management of partic-
ipants and additional refresher training on intervention
components and group facilitation skills through role
play. The supervisors are in turn provided with supervi-
sion by the master trainer, conducted fortnightly via
Skype and also lasting 2 to 3 h. Intervention fidelity is
monitored through independent observations of 15% of
randomly selected sessions of each facilitator against tai-
lored checklists. These fidelity checks are conducted by
persons trained in PM+ Group but not acting as study
facilitators or supervisors.
Enhanced usual care (EUC)
Control and intervention arm participants will continue
to receive routine LHW visits on an individual basis.
The care that they receive is considered to be EUC as
usual care for common mental disorders in primary care
in Pakistan typically involves no or placebo care leaving
the majority of cases of distress undetected and unsup-
ported. EUC will comprise:
1. Providing LHWs and primary health care providers
with training in the detection and management of
mental health care needs, and referral pathways
2. Providing feedback to all participants about their
assessment results
3. Providing all participants with information about the
options for seeking appropriate care for distress (i.e.
through their LHW, the BHU, or the tertiary health
care centre)
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Both arms have unrestricted access to EUC through
their routine health providers. The intensity of services
received in both arms will be measured at 20 weeks as
part of the economic evaluation (see below).
Participant recruitment
Participant inclusion criteria
Cluster eligibility requires that women are living in the
catchment area of LHWs participating in the trial. Indi-
vidual eligibility criteria are that participants are women
aged 18–60 years who screen positive on the screening
tools and do not have acute medical conditions that
would preclude them from attending PM+ Group ses-
sions. Given the group intervention format, which seeks
women facing similar life experiences, an upper age limit
of 60 years was deemed appropriate as the life experi-
ences of women in the upper age cohort are considered
different from those of younger women.
Inclusion criteria to be invited for trial participation
are: scoring both (1) above 2 on the General Health
Questionnaire for common mental disorders (GHQ-12)
[29, 30] and (2) above 16 on the WHO Disability Assess-
ment Schedule for functional impairment (WHODAS)
[31]. The GHQ-12 is a screening tool for identifying
minor mental disorders in the general population, and
consists of 12 questions scored on a 4-point Likert scale.
When used for screening the GHQ-12 is scored bi-
modally (i.e. 0–0–1–1), with a score range of 0–12. In
previous studies in Pakistan a cut-off of 2 or higher has
been reported to indicate caseness of mental disorder
[29, 32, 33]. The WHODAS is a generic instrument
assessing health and disability. It is applicable across all
diseases, including mental disorders; and can be used
with adult populations across cultures. WHODAS as-
sesses difficulties that people are facing across six do-
mains of functioning (cognition, mobility, self-care,
getting along, life activities, and participation) during the
last 30 days due to their illness. Difficulties are scored
on a 5-point Likert scale of: none, mild, moderate, se-
vere, or extreme. In this study the 12-item interviewer
administered version will be used. Both measures will be
used to only include those women experiencing psycho-
logical distress and impaired functioning.
Following screening, women will be verbally informed
that assessment results indicate they are eligible for the
trial. They will be informed about the study and invited
to complete a more comprehensive baseline assessment.
For women who do not meet the eligibility criteria, their
results and reasons for study ineligibility will be verbally
explained to them.
Participant exclusion criteria
Women will be assessed for the following exclusion cri-
teria: (1) imminent risk of suicide as defined in the
mhGAP intervention guide [34], (2) a severe mental dis-
order (e.g. psychosis, drug or alcohol dependence), or
(3) severe cognitive impairment (e.g. developmental dis-
ability or dementia) as assessed by the research team.
Those meeting any of these criteria will be excluded and
referred to the local Psychiatry Department in Saidu
Teaching Hospital, Swat, or to BHUs, depending upon
their needs. Additionally, women meeting the inclusion
criteria are asked if they plan on moving out of the area
during the study period (3 months); such women are ex-
cluded due to unavailability for follow-up.
Procedure to identify eligible participants
Women will be identified using a procedure that in-
volves LHWs developing a list of households in her
catchment area. Using a computer-generated random
numbers list the research coordinator selects the house-
hold screening order for the LHW to orally inform the
head of each household about the study and seek agree-
ment for the research team to attend and conduct
screening. This step addresses community suspicion and
conservative community norms that prevent researchers
attending homes uninvited.
If in agreement, the LHW will make a list of all
women aged 18–60 years in identified households, to
which the research coordinator will apply a computer-
generated random numbers list to determine the order
for the research team to screen eligible women in each
household. Two attempts will be made to reach each
woman before moving to the next on the list. Once a
woman has screened positive, consented to participate
in the trial, and completed baseline assessments no fur-
ther screening will take place in that household. Should
a woman screen positive and meet the eligibility criteria
but decline to take part in the research then screening of
other women in that household will continue. This en-
sures that only one woman from each household partici-
pates in the study to protect the confidentiality of
problems revealed in PM+ Group sessions.
Informed consent
Informed consent follows a two-step procedure which
seeks to respect conservative norms whereby family per-
mission is required for women to participate in research,
as well as to mitigate against perceived hospitality norms
that may motivate agreement to participate. First, poten-
tially eligible women will be approached by the research
team for written informed consent for screening. If the
woman screens positive she will be invited to participate
and provided with full trial informed consent. Written
informed consent will be obtained at baseline assess-
ments, which will take place at least 24 h after the Infor-
mation Sheet and Consent Form have been shared and
discussed with participants. Reasons for refusal to
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participate at either stage will be documented. At the 7-
week and 20-week assessments researchers will verbally
reaffirm consent with participants. For the qualitative
component separate written informed consent will be
taken at the time of interview.
Sample size and power calculations
Similar community-based intervention studies using
change in symptom-based questionnaires, like the Hos-
pital Anxiety and Depression Scale (HADS) [35–37],
have used effect sizes of at least 0.4 when testing treat-
ment as usual groups with limited or no active thera-
peutic elements, as we propose. Assuming an effect size
of 0.4 for the primary endpoint (HADS total score at
20 weeks), with 90% power and 5% significance, an
intracluster correlation coefficient of 0.05, and a two-
sided hypothesis test with 34 health worker catchment
area clusters randomised at a 1:1 allocation ratio, and ac-
counting for 20% attrition, we will need 612 participants
(i.e. 306 in each arm). This means that we will need on
average 18 participants from each of the 34 health
worker catchment areas. A pilot study conducted a
nearby Union Council found that these recruitment
numbers were feasible and achievable [27], and previous
research in the same setting identified a high prevalence
of mental health problems in women [38].
Randomisation
Thirty-four LHW clusters will be randomised to the
intervention and control arms on a 1:1 allocation ratio
using a permuted-block randomisation method (see
Fig. 2). A randomisation list will be generated by an in-
dependent statistician using SAS PROC PLAN. Alloca-
tion of clusters will be carried out by an independent
person based at the Human Development Research
Foundation, Islamabad. This is achieved by the research
team sharing a list of LHWs each with a corresponding
number. Allocation status will be communicated to the
research team coordinator who will inform respective
LHWs after consent for trial participation is obtained
from participants by researchers.
If a catchment area is allocated to the intervention arm,
the LHW contacts all participants within her cluster to
schedule an initial meeting to introduce the participant to
the intervention facilitator. This is a necessary engagement
step in this setting where service uptake is dependent
upon a trusted relationship with the service provider. If al-
located to the control arm the LHW continues routine
visits to women in her catchment area.
Outcome measures
Primary outcome
The primary outcome is levels of individual psycho-
logical distress, measured by levels of anxiety and
depression on the HADS [35] at 20 weeks. This 14-item
scale consists of two subscales: HADS-A comprising
seven items measuring anxiety, with a score range of
0–21; and HADS-D comprising seven items measur-
ing depression, with a score range of 0–21. Higher
scores indicate higher levels of anxiety and/or depres-
sion. The Urdu version of the HADS has shown ac-
ceptable validity and reliability [39].
Secondary outcome measures
Secondary outcomes include depressive disorder mea-
sured by the Primary Health Questionnaire [40–42];
post-traumatic stress disorder (PTSD) symptoms mea-
sured by the Post-traumatic stress disorder Check List
(PCL-5) [43]; levels of social support measured by the
Multi-dimensional Scale of Perceived Social Support
(MSPSS) [44]; and levels of functioning as assessed by
WHODAS [31]. Costs of health care are measured
using the Client Service Receipt Inventory (CSRI)
[45]. Self-report wellbeing outcomes are assessed
using the Psychological Outcomes Profile Instrument
(PSYCHLOPS) [46]. Table 1 indicates the time points
for administering each instrument.
Briefly, the Patient Health Questionnaire-9 (PHQ) is a
9-item instrument measuring the likely presence and se-
verity of depressive disorder against the Diagnostic and
Statistical Manual of Mental Disorders, fourth edition
(DMS-IV) [42]. It uses a 4-point Likert scale where
symptom severity is rated over the last 2 weeks from not
having the symptom at all, to having it nearly every day.
The sum of items gives the total score, with a cut-off of
≥10 as the most accurate for detecting depression [47].
The PHQ has been validated in Urdu [40, 41].
The PCL-5 is a 20-item checklist corresponding to the
20 DMS V PTSD symptoms, and has been previously
used in Pakistan [48]. Items are rated on a scale of 0–4,
with a total severity score of 80. The PCL-5 has been
adapted to ask for symptoms in the last week, rather
than the last month, to enhance sensitivity to change.
The MSPSS is a self-rating tool of perceived social
support containing 12 questions rated on a 7-point
Likert scale, with higher scores indicating higher levels
of social support [44]. Questions correspond to three
categories of support: from family, friends, and signifi-
cant other. It has been translated into Urdu and vali-
dated with a Pakistani population [49].
The CSRI will be used to collect data on service utilisa-
tion and characteristics of people experiencing distress as
the basis for calculating the costs of care for health [45]. It
has been translated and adapted for use in Pakistan.
PSYCHLOPS is a self-report measure consisting of
four questions across three domains: problems (two
questions), function (one question), and wellbeing (one
question). Responses are scored by domain on an ordinal
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Fig. 2 Schedule of enrolment, interventions, and assessments
Table 1 Assessment instruments and administered time point
Concept (instrument) Screening Baseline assessments 7-week assessment 20-week assessment
Depression and anxiety
(Primary outcome)
HADS HADS HADS
Functioning WHODAS WHODAS WHODAS
Distress – common mental disorder GHQ-12
Depressive disorder PHQ-9 PHQ-9 PHQ-9
Adverse life events Section 1 of HTQ
Life Events Checklist for Pakistan
Symptoms of post-traumatic Stress Disorder PCL-5 PCL-5 PCL-5
Perceived social support MSPSS MSPSS MSPSS
Cost of health care CSRI CSRI
Self-reported wellbeing PSYCHLOPS PSYCHLOPS PSYCHLOPS
CSRI Client Service Receipt Inventory, GHQ General Health Questionnaire for common mental disorders, HADS Hospital Anxiety and Depression Scale, HTQ Harvard
Trauma Questionnaire, MSPSS Multi-dimensional Scale of Perceived Social Support, PCL Post-Traumatic Stress Disorder Check List, PHQ Patient Health
Questionnaire-9, PSYCHLOPS Psychological Outcomes Profile Instrument, WHODAS WHO Disability Assessment Schedule for functional impairment
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6-point scale with a maximum score of 20. The during-
therapy and post-therapy versions of PSYCHLOPS consist
of the same four questions, with the post-therapy version
containing an additional overall valuation question deter-
mining self-rated outcome ranging from ‘much better’ to
‘much worse’. PSYCHLOPS has been validated in primary
care populations across several countries [50, 51].
Other measures
Also assessed at 20 weeks are adverse life events measured
using two instruments: firstly, Section 1 of the Harvard
Trauma Questionnaire (HTQ) which includes 17 items
describing traumatic events [52], validated in Pakistan
[53]. In addition, day-to-day life events will be assessed
using a life-events measure developed for women in
Pakistan [36]. Both the HTQ and life-events measure con-
tain additional questions about whether events have oc-
curred since trial enrolment to enhance sensitivity.
Further data
At baseline we will also collect demographic data on
each participant, including age, marital status, years of
schooling, and occupation of the woman. Where applic-
able we will also collect data on number of children and
their ages, and years of schooling and occupation of the
woman’s husband. Research assistants also subjectively
assess the socioeconomic status of the household using
a locally developed rating scale.
Qualitative evaluation
Semistructured interviews will be conducted with a ran-
dom subsample of intervention facilitators; LHWs; inter-
vention participants with an equal number of completers
and dropouts; control arm participants; senior staff with
policy implementation responsibilities/connected to the
research (i.e. receiving referrals of excluded study partic-
ipants); research assistants; and family members of inter-
vention participants with an equal number of
intervention completers and dropouts. We anticipate up
to six interviews with each category of respondent, with
sampling determined by saturation. Interviews follow a
semistructured topic guide that address topics relevant
to each category of respondent (see Table 2).
Qualitative interviews and data analysis will be con-
ducted by a pair of researchers independent of the re-
search and intervention teams to avoid biasing
responses. Researchers will be trained in the key princi-
ples of qualitative interviewing and also provided with
supervision throughout data collection. Due to local
community suspicions it is not possible to audio-record
interviews; therefore, all interviews will be recorded in a
written verbatim transcript produced as the interview is
conducted [54]. Analysis will be conducted manually fol-
lowing an established thematic approach [54, 55].
Masking
Due to the nature of the intervention it is not possible
to mask participants, LHWs, and intervention facilita-
tors and co-facilitators to treatment allocation. All re-
searchers conducting quantitative outcome assessments
will be masked, while the qualitative research team will
be unmasked. Researchers conducting assessments are
residents of the local Swat District and remain distinct
to the intervention facilitation and co-facilitator teams
with separate offices, logistical arrangements, and ad-
ministrative management. They are trained and super-
vised by the site principal investigator (PI; NK).
Prior to each assessment point participants are
instructed by LHWs not to disclose to researchers their
allocation status. The researcher completes a form to
guess which arm of the trial the participant belongs to
both preceding and following the conduct of each as-
sessment. The order of assessments ensures that the
primary outcome measure (HADS) is administered first
to minimise the risk of bias should masking be compro-
mised. If unmasking does occur this will be docu-
mented, the assessment halted, and a new researcher
assigned to complete assessments with that participant.
The CSRI is administered as the final instrument at the
20-week assessment to minimise the impact upon as-
sessments should responses lead to unmasking.
The trial statistician (DW) is blinded to the treatment
code when developing the statistical analysis plan and
writing the statistical programmes, which will be vali-
dated and completed using dummy randomisation
codes. The actual allocation will only be provided after
locking of the database.
Data management
Quantitative data will be completed on paper assessment
booklets with assigned participant codes, stored at the
research field office at the end of each day. Daily check-
ing of data will be performed by the research coordin-
ator, with queries identified and resolved promptly.
Double data entry will be conducted by an assigned data
entry team at the Human Development Research Foun-
dation (HDRF) in Islamabad, with discrepancies resolved
by a third data entry person. Once in an electronic file,
all data will be password-protected, with data managers
controlling access to the passwords and the database
backed up daily.
Qualitative data will be stored in paper format in
locked filing cabinets in the research field office at the
end of each day. None of the qualitative data will contain
identifiers (name, age, category of respondent, etc.) that
may compromise participant anonymity.
All other process data (i.e. supervision forms) will be
stored in locked filing cabinets in the intervention field of-
fice. Intervention team members have been trained in the
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importance of de-identifying all notes relating to participant
progress through the intervention to ensure confidentiality.
Statistical methods
Data will be analysed using SAS 9.3 and SPSS Version
21. Findings will be reported according to the Consoli-
dated Standards of Reporting Trials (CONSORT) guide-
lines for cRCTs [56]. Primary analyses will be based on
the intention-to-treat population and secondary analyses
will be based on the per-protocol population. A linear
mixed model will be employed for the primary endpoint
analysis. The mixed model will have treatment, visit,
interaction between treatment and visit as fixed effects,
baseline measurement of HADS as covariate, and cluster
and subject as random effects. The mean difference be-
tween two treatment arms at each visit, together with its
95% confidence interval (CI), will be derived from the
mixed model. Covariate-adjusted mixed model of pri-
mary endpoint will also be performed by adding prespe-
cified covariates at baseline into the above model.
Missing data will be treated as missing at random in the
mixed model analysis and no imputation of primary
endpoint will be made. To assess the sensitivity of the
result to this assumption, the last observation carried
forward strategy will be used to compute missing pri-
mary endpoints. Subgroup analysis will be performed on
the prespecified covariates.
Continuous secondary outcomes will be analysed in a
similar way as the primary endpoint analysis. For the
analysis of binary secondary outcomes, a generalised
mixed model will be employed with treatment, visit,
interaction between treatment and visit as fixed effects,
baseline measurement as covariate, and cluster and sub-
ject as random effect. The odds ratio between two
Table 2 Qualitative evaluation
Category of respondent Topics to be explored
Intervention facilitators Overall impressions of PM+ Group
Experiences of PM+ Group training and supervision
Rapport with participants and families of participants
Views on the group delivery format
Experiences of participants’ intervention adherence and strategies to keep participants motivated
View on intervention scalability
LHWs Overall impressions of PM+ Group
Strategies to keep participants motivated to attend the groups and experiences of participants
intervention adherence
View on intervention scalability with LHW as entry point into primary healthcare
Intervention participants – completers Overall impressions of PM+ Group
Rapport with group facilitators
Intervention adherence
Burden of research interviews
Intervention participants – drop outs Reasons for stopping attending PM+ Group
If appropriate:
Rapport with group facilitator
Intervention acceptability
Burden of research
Control arm participants Experiences of research, including participants and family views of the research assistants and
research procedures
Views of the questions researchers asked
Senior staff with policy implementation roles/
connected to the research
Overall understanding and impressions of PM+ Group
Existing scope of work of primary health care system in Pakistan, with a focus on LHW role
Views on possible routes for integration and scale-up of PM+ Group into Pakistan primary health
care systems
Research assistants Views of assessment training and supervision
Experiences of conducting research assessments, including the appropriateness of individual
instruments, problems relating to masking, and experiences of participant distress
Family members of participants Overall understanding and impressions of PM+ Group
Where appropriate:
Views of the impact of PM+ Group upon the participant in the family
Views of the research assistants and assessments
LHW Lady Health Worker
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treatment arms at each visit together with its 95% CI will
be derived from the generalised mixed model.
All analyses will be described in detail in the finalised
and signed statistical analysis plan before unmasking
the study.
Economic analysis
Health economic analysis will be conducted to deter-
mine the difference in costs and outcomes in the inter-
vention arm as compared to the control arm.
We take a broad public health and societal perspective
to assessing economic implications, including all direct
cost of health, social, voluntary and private sector ser-
vices accessed by participants; productivity losses of the
participant and caregivers; and informal care and out-of-
pocket expenses.
Primary analysis will be of total costs over the 20-week
follow-up treatment period. Recognising that cost data are
often skewed, the bootstrap technique will be applied. The
sampling with replacement from the original observed
paired of costs and effects will be employed to maintain
the correlation structure between costs and benefits, and
bootstrapping sampling will be repeated 1000 times. For
each bootstrap sample, an estimate of differential total
mean costs and expected mean effectiveness will be calcu-
lated. The 95% CIs for the differential estimates will be de-
rived from the 2.5th and 97.5th percentiles [57, 58].
Cost-effectiveness will be assessed by combining costs
with the outcome measures including (1) HADS-A and
HADS-D scores and (2) WHODAS total score in incre-
mental cost-effectiveness analysis. Repeat resampling
from the costs and effectiveness data (bootstrapping)
will be used to calculate the probability that each of the
treatments is the optimal choice, subject to a range of
possible maximum values (ceiling ratio) that a decision-
maker might be willing to pay for a unit improvement in
HADS-A and HADS-D scores, and WHODAS scores.
The results of the cost-effectiveness will be reported as
incremental cost-effectiveness ratios, and acceptability
curves which summarise the information contained in a
cost-effectiveness plane [59].
Ethical considerations
The trial protocol has received ethical approval from the
Institute of Psychiatry, Benazir Bhutto Hospital, Rawalpindi,
Pakistan and the World Health Organisation Ethical
Review Board. The study has also received support
from the Swat District Health Department and People’s
Primary Healthcare, and from the Psychiatry Depart-
ment at Saidu Teaching Hospital, Swat.
Trial management
Overall trial management is provided by a Project Steer-
ing Committee comprised of all senior research and
intervention staff, local and international PIs, technical
experts, and external advisors who meet fortnightly dur-
ing trial recruitment and follow-up, and monthly follow-
ing the completion of endpoint assessments. The Project
Steering Committee receives reports from the Trial
Management Committee comprised of local research
and intervention teams responsible for day-to-day trial
conduct. A Trial Advisory Board comprised of persons
independent of the trial with expertise in trial manage-
ment and local culture meets monthly. This board is
chiefly responsible for reviewing all adverse reactions
and serious adverse events (SAEs) to determine if they
are attributable to the trial.
Adverse event monitoring
All adverse reactions and SAEs reported spontaneously
by the participant, or observed by research or interven-
tion staff, will be recorded. An event is considered a po-
tential SAE if it is an undesirable experience occurring
to a participant during the study, whether or not consid-
ered related to the research procedure. The chair or a
nominated person from the Trial Advisory Board will re-
view SAEs within 48 h, deciding if it is likely related or
unrelated to the intervention; and the Trial Advisory
Board will review all adverse reactions twice a month. In
both instances, the Trial Advisory Board will determine
if any appropriate action in respect of ongoing trial con-
duct is necessary and specify what action this would be
(i.e. referral to specialised care). The site PI will inform
trial participants and those bodies providing ethical
oversight if anything occurs on the basis of which it ap-
pears that the disadvantages of participation may be sig-
nificantly greater than was foreseen.
Discussion
The PM+ Group trial will provide evidence on the ef-
fectiveness of an empirically supported group psycho-
logical intervention delivered by nonspecialists in rural
Pakistan, complemented by qualitative data on interven-
tion acceptability. While various components of PM+
strategies have been proven effective [23], the combin-
ation of these strategies into a brief (five sessions) trans-
diagnostic structured group intervention delivered by
nonspecialists in humanitarian settings has not been ex-
amined before. Critically, this study builds upon results
of an individual PM+ trial [20], addressing access bar-
riers for women by adapting the intervention to a
community-based group format delivered in partnership
with LHWs who are trusted and embedded community
health professionals. If proven effective, WHO will make
the intervention freely available on its frequently accessed
website. The potential benefits of providing multiple inter-
vention formats for reaching populations in need in a scal-
able and sustainable manner, addressing a range of needs
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in a cost-effective way, have made the case for this study
all the more compelling.
Trial status
Trial recruitment commenced December 2015 and, at
the time of manuscript submission, was ongoing. Results
of this study are expected in 2017.
Additional file
Additional file 1: SPIRIT 2013 Checklist: recommended items to address
in a clinical trial protocol and related documents. (DOCX 51 kb)
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